Clarivate (CLVT) drew fresh attention after law firm Sterne, Kessler, Goldstein & Fox announced a co-development partnership focused on AI-driven patent workflow tools integrated into Clarivate’s Rowan Patents platform.
The partnership headlines arrive as Clarivate trades at US$1.87, with a 7-day share price return of 5.65% and a 30-day share price return of 5.06%. However, longer term momentum has been weak, with the year-to-date share price down 42.28% and the 5-year total shareholder return falling 92.03%. This suggests that recent interest is emerging against a backdrop of heavy past losses and shifting views on future execution risk.
Seize this moment around Clarivate's AI push to scan a hand-picked 39 profitable AI stocks that aren't just burning cash that already combine real earnings with exposure to similar tech themes.After a sharp long term slide and a short burst of AI-fueled interest, Clarivate now forces a choice: lean into this reset level today or wait for a clearer valuation cushion first?
Most Popular Narrative: 37% Undervalued
Clarivate last closed at $1.87, compared with a widely followed fair value estimate of $2.97. This frames the stock as meaningfully discounted while the AI story and rebuilding plan are still being tested.
Rapid expansion and adoption of AI-driven product innovation across all segments (including new AI-powered analytics in Web of Science, Derwent, and Cortellis) enhances product differentiation and workflow integration, driving higher pricing, customer retention, and potentially expanding gross margins.
See why 5 investors see Clarivate as 37% undervalued.
Result: Fair Value of $2.97 (UNDERVALUED)
Still, Clarivate’s reliance on pressured higher education budgets, along with the ongoing shift toward free or Open Access research tools, could undercut the AI-led recovery story.
Find out about the key risks to this Clarivate narrative.
Next Steps
Sentiment on Clarivate is split, with the AI story pulling in fresh interest while past losses still weigh on confidence. Move quickly to check the underlying risk and reward balance for yourself and see how the full picture looks through 3 key rewards and 1 important warning sign
Looking for more investment ideas beyond Clarivate?
Clarivate may be front of mind today, but your next opportunity could be sitting elsewhere in the market. Do not leave that upside on the table.
- Target resilient income by reviewing companies tagged as 5 dividend fortresses and see which payouts align with your need for yield and balance sheet support.
- Hunt for potential mispricing through a curated 29 high quality undervalued stocks that filters for quality fundamentals, not just cheap tickers on a screen.
- Spot potential future leaders early with a focused 21 high quality undiscovered gems where solid businesses have yet to attract broad investor attention.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com